Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics
- 23 June 2011
- journal article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 18 (2) , 313-322
Abstract
Context: Colchicine (CLC) causes cell death by destabilizing the tubulin unit. However, it ionizes at physiological pH resultant low bioavailability and therapeutic efficacy. Objectives: We have attempted to augment the bioavailability of CLC by fabricating the inclusion complex with hydroxypropyl-β-cyclodextrin (HP-β-CD). Materials and methods: CLC-HP-β-CD inclusion complex was prepared and evaluated with Fourier-transform infrared spectroscopy, differential scanning calorimetry, powder X-ray diffractometry, scanning electron microscopy, 1H nuclear magnetic resonance (1H NMR) spectroscopy and rotating frame overhauser enhancement spectroscopy (ROESY). Oral bioavailability of CLC-HP-β-CD inclusion complex was analyzed using high performance liquid chromatography method. Results and discussion: Our phase-solubility data indicated the formation of a stable complex with Kc ~0.31 mM−1 at pH 7.4. 1H NMR ascertains that NHCOCH3 moiety of CLC enters in the HP-β-CD cavity and deshielded the H-3 and H-5 protons. ROESY also correlates the Hf and Hg of CLC with H-3 and H-5 protons of HP-β-CD and indicates that Hf and Hg protons of CLC are present either as cis and/or trans form in CLC-HP-β-CD inclusion complex. Pharmacokinetic studies showed a 1.82-fold increase in absolute bioavailability of CLC upon complexation. Conclusion: CLC-HP-β-CD inclusion complex may potentially be used as a viable formulation of CLC.Keywords
This publication has 11 references indexed in Scilit:
- Inclusion complexes of noscapine in β-cyclodextrin offer better solubility and improved pharmacokineticsCancer Chemotherapy and Pharmacology, 2009
- Characterization of ternary complexes of meloxicam-HPβCD and PVP or L-arginine prepared by the spray-drying techniqueActa Pharmaceutica, 2008
- Inclusion complexes of pyrimethamine in 2-hydroxypropyl-β-cyclodextrin: Characterization, phase solubility and molecular modellingBioorganic & Medicinal Chemistry, 2007
- Cyclodextrins as pharmaceutical solubilizersAdvanced Drug Delivery Reviews, 2007
- Studies on curcumin and curcuminoidsInternational Journal of Pharmaceutics, 2007
- Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrinsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. Preparation and properties of rofecoxib hydroxypropyl β-cyclodextrin inclusion complex: A technical noteAAPS PharmSciTech, 2005
- Prolonged cytotoxic effect of colchicine released from biodegradable microspheresJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2004
- 19F and 1H NMR Investigation of Cyclodextrin/Fluorocarbon Alkyl Carboxylate Surfactant Inclusion ComplexesLangmuir, 1998
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996